US approves Roche drug for late-stage melanoma
Wednesday, August 17, 2011 - 11:01
in Health & Medicine
The US Food and Drug Administration on Wednesday approved a new drug, Zelboraf, to treat late-stage melanoma, the most dangerous type of skin cancer, after it was shown to extend patients' survival.